|
|
|
|
| LEADER |
05124nmm a2200277 u 4500 |
| 001 |
EB000713732 |
| 003 |
EBX01000000000000000566814 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9789400974395
|
| 100 |
1 |
|
|a Korelitz, B.I.
|e [editor]
|
| 245 |
0 |
0 |
|a Inflammatory Bowel Disease
|h Elektronische Ressource
|b Experience and Controversy
|c edited by B.I. Korelitz
|
| 250 |
|
|
|a 1st ed. 1982
|
| 260 |
|
|
|a Dordrecht
|b Springer Netherlands
|c 1982, 1982
|
| 300 |
|
|
|a 246 p
|b online resource
|
| 505 |
0 |
|
|a 14 What is the Role of Sigmoidoscopy and Rectal Biopsy in Inflammatory Bowel Disease? -- 15 Where Has Colonoscopy Had Its Greatest Value in the Management of Inflammatory Bowel Disease? -- 16 The Significance of Microgranulomas in Crohn’s Disease -- 17 Scanning Electronmicroscopic Appearance of “Early” Lesions in Crohn’s Disease -- 18 Has There Been Any Progress in the X-ray Diagnosis and Differential Diagnosis of Inflammatory Bowel Disease? -- 19 When in the Course of Crohn’s Disease Should X-ray Studies be Performed? -- IV Moderator: Felicien M. Steichen, MD -- 20 Recurrence Rates After Surgery for Crohn’s Disease and Their Implications Regarding Indications for Surgery (As Seen by the Gastroenterologist) -- 21 Indications for Surgery in Crohn’s Disease (As Seen by the Colon and Rectal Surgeon) -- 22 What is the BestManagement of Perirectal Abscess and Fistula in Crohn’s Disease? -- 23 An Appraisal of Surgical Procedures for Crohn’s Disease --
|
| 505 |
0 |
|
|a I Moderator: Burton I. Korelitz, MD -- 1 The History of Crohn’s Disease -- 2 An Internist’s View of Inflammatory Bowel Disease -- 3 Evidence for Crohn’s Disease as an Extensive Process -- 4 Implications of Uveitis and Other Extraintestinal Manifestations of Inflammatory Bowel Disease -- 5 Environment vs Heredity in Inflammatory Bowel Disease -- 6 Is There an Immunological Contribution to Inflammatory Bowel Disease? -- Is Investigation Headed in the Right Direction? -- II Moderator: Harry D. Fein, MD -- 8 What is Considered Good Medical Care in Crohn’s Disease? -- 9 What is the Role of Immunosuppressive Therapy in Inflammatory Bowel Disease? -- 10 Hematologic Complications of Inflammatory Bowel Disease and Its Drug Therapy -- 11 The Role of Hyperalimentation in the Treatment of Crohn’s Disease -- 12 Inflammatory Bowel Disease in the Elderly -- 13 Special Problems of Adolescents with Inflammatory Bowel Disease -- III Moderator: Burton I. Korelitz, MD --
|
| 505 |
0 |
|
|a V Moderator: Jerome D. Waye, MD -- 24 What is the Best Medical Management for Ulcerative Colitis? -- 25 Why Do Results of Management of Toxic Megacolon Differ? -- 26 An Appraisal of the Cancer Problem in Ulcerative Colitis -- 27 The Problems Arising in Diagnosis of Dysplasia as a Premalignant Lesion in Ulcerative Colitis -- 28 A Program for Management of Ulcerative Colitis With Respect to Cancer -- Special Presentation -- 29 Why Is There a Foundation for Patients with Inflammatory Bowel Disease? -- VI Moderator: Norman Sohn, MD -- 30 What Problems Lie Ahead for a Patient With an Ileostomy? -- 31 The Continent (Kock) Ileal Reservoir: Technique and Indications -- 32 Experience and Late Results with the Continent Ileostomy -- 33 An Appraisal of the Results of the Continent Ileostomy (As Seen by the Gastroenterologist)
|
| 653 |
|
|
|a Gastroenterology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 028 |
5 |
0 |
|a 10.1007/978-94-009-7439-5
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-94-009-7439-5?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.33
|
| 520 |
|
|
|a Grouping ulcerative colitis with Crohn's disease (Inflammatory Bowel Disease) in a teaching seminar has historical support. The medical literature includes descriptions of both diseases in the latter half of the 19th century; they share many symptoms; in some instances, differentiating them may be very difficult; and the cause of each remains unknown. Furthermore, one member of a family may suffer with Crohn's disease while another has ulcerative colitis. And both processes are prone to the late complications of carcinoma at a site of previous involvement. Finally, the investigators and students of one disease have usually also contributed to the understanding of the other disease. The incidence of Crohn's disease seems to be increasing rapidly. This has been sug gested by reports from Sweden, the Netherlands, England, Scotland, and South Africa as well as the United States. Though methods of recording data vary, the increase is further supported by cases of greater virulence, still younger ages of onset, and more cases in the elderly. This is remarkable when we consider that fifty years ago, when the classic description from Mt. Sinai Hospital was being prepared, the disease was rare. Since the cause remains elusive, we must try to cope with this entity as skillfully as we can, with consideration of indications, and timing of drug and surgical intervention. The choice of forms of management has been controversial, even among the most experi enced physicians
|